The history and accomplishments of the ICGG Gaucher registry

This publication has 39 references indexed in Scilit:

• Long‐term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment
  Journal of Inherited Metabolic Disease, 2012
• Revised recommendations for the management of Gaucher disease in children
  European Journal of Pediatrics, 2012
• Reducing selection bias in case-control studies from rare disease registries
  Orphanet Journal of Rare Diseases, 2011
• Disease Registries and Outcomes Research in Children
  Pediatric Drugs, 2011
• Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
  Orphanet Journal of Rare Diseases, 2011
• Osteopenia in Gaucher disease develops early in life: Response to imiglucerase enzyme therapy in children, adolescents and adults
  Blood Cells, Molecules, and Diseases, 2011
• Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis
  British Journal of Haematology, 2009
• Management of non‐neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring
  Journal of Inherited Metabolic Disease, 2008
• Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations
  The Journal of Pediatrics, 2004
• Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase
  The Journal of Pediatrics, 1996